Published in
Springer Nature [academic journals on nature.com], Bone Marrow Transplantation, 7(56), p. 1700-1709, 2021
DOI: 10.1038/s41409-020-01198-2
Links
Tools
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Journal article published in 2021 by
Benoit Tessoulin 
,
David Chiron,
Catherine Thieblemont,
Lucie Oberic,
Kamal Bouadballah,
Emmanuel Gyan ,
Gandhi Damaj ,
Vincent Ribrag,
Rémy Gressin,
Pierre Feugier,
Olivier Casasnovas ,
Hacène Zerazhi,
François Lemonnier,
Hervé Maisonneuve,
Clementine Joubert
and other authors.
,
David Chiron,
Catherine Thieblemont,
Lucie Oberic,
Kamal Bouadballah,
Emmanuel Gyan ,
Gandhi Damaj ,
Vincent Ribrag,
Rémy Gressin,
Pierre Feugier,
Olivier Casasnovas ,
Hacène Zerazhi,
François Lemonnier,
Hervé Maisonneuve,
Clementine Joubert
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 